Physician

William Lance Garner, M.D.

According to 2025 Medicare claims, William Garner, M.D. (NPI: 1740291517) practices interventional cardiology in the Oklahoma City, OK market, with the plurality of this provider's patient population coming from Oklahoma, OK. This provider's primary affiliated billing organization is CARDIOVASCULAR HEALTH CLINIC PLLC (NPI: 1215324553; TIN: 473646676) and primary practice location at 73134-2699. Garner is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Garner's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,574 traditional Medicare patients, billed 9,268 HCPCS/CPT codes, and received $1,562,446 in Medicare payments. The top billing code was 78431 (Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan). Part D data shows 4,224 prescription claims across 608 beneficiaries totaling $628,482 in drug costs, led by Eliquis (Apixaban). 2015 DME data shows 15 claims. Open Payments data shows 14 records totaling $412. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $192,369 to $1,562,446. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $269,541 to $628,482. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,044	2,982	$192,369
2016	1,504	3,373	$206,081
2017	1,292	3,547	$220,094
2018	1,433	3,751	$221,902
2019	540	1,471	$114,218
2020	343	1,596	$194,934
2021	1,190	4,851	$836,053
2022	1,513	6,531	$1,105,249
2023	1,681	8,155	$1,176,189
2024	1,574	9,268	$1,562,446

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	351	4,504	$269,541
2016	347	4,257	$246,873
2017	364	3,297	$215,044
2018	348	3,013	$292,524
2019	320	1,749	$205,647
2020	203	1,113	$126,027
2021	296	1,934	$257,295
2022	392	2,645	$446,573
2023	506	3,543	$554,842
2024	608	4,224	$628,482

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	15	$1,333
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
78431	Nuclear medicine studies of blood flow in heart muscle at rest and with stress with concurrent ct scan	570	599	$672
93306	Ultrasound of heart with color-depicted blood flow, rate, direction and valve function	520	542	$120
93015	Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician	587	587	$49
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	525	756	$12
J2785	Injection, regadenoson, 0.1 mg	561	2,244	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	253	11,741	$225,502
Xarelto	Rivaroxaban	97	5,057	$93,021
Multaq	Dronedarone Hcl	41	1,770	$47,702
Ozempic	Semaglutide	31	1,036	$33,466
Repatha Sureclick	Evolocumab	49	1,372	$26,307

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	14	$412	E.R. Squibb & Sons, L.L.C.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for William Lance Garner, M.D.?

Tedicare shows public-source Medicare data for William Lance Garner, M.D. (NPI 1740291517), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does William Lance Garner, M.D. have ACO affiliation data?

William Lance Garner, M.D. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to William Lance Garner, M.D.?

William Lance Garner, M.D. is linked to CARDIOVASCULAR HEALTH CLINIC PLLC (billing NPI 1215324553) in the available physician profile data.

Does William Lance Garner, M.D. have Open Payments data?

William Lance Garner, M.D. has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.